Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00000332 · ClinicalTrials.gov registry record · Phase 2
High Dose Nimodipine Treatment Adjunct - 1
A Phase 2 study, sponsored by National Institute on Drug Abuse (NIDA).
- Completed
- Registry status
- Phase 2
- Development phase
NCT00000332 is a Phase 2 study that has completed, run by National Institute on Drug Abuse (NIDA).
The verdict
NCT00000332, a Phase 2 study, has completed, sponsored by National Institute on Drug Abuse (NIDA).
- COMPLETED
- Registry status
- Phase 2
- Development phase
Study Summary
The purpose of this study is to determine if nimodipine is more effective than placebo in reducing stimulated craving for cocaine in cocaine dependent individuals denied access to cocaine in inpatient unit.
Interventions
- DRUG Nimodipine
Trial Details
| Field | Value |
|---|---|
| Start Date | 1998-05 |
| Est. Completion | 2000-04 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00000332
The ClinicalTrials.gov registry entry for NCT00000332 describes a study currently listed as completed, categorized as Phase 2. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is National Institute on Drug Abuse (NIDA), which has 335 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Nimodipine is the first listed.
NCT00000332 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00000332 about?
NCT00000332 is a clinical study titled "High Dose Nimodipine Treatment Adjunct - 1". The purpose of this study is to determine if nimodipine is more effective than placebo in reducing stimulated craving for cocaine in cocaine dependent individuals denied access to cocaine in inpatient unit.
What is the current status of trial NCT00000332?
This trial is currently completed. It is a Phase 2 study. The study started on 1998-05. Estimated completion is 2000-04.
What interventions are being tested in trial NCT00000332?
The interventions under investigation include: Nimodipine (DRUG).
Who is sponsoring clinical trial NCT00000332?
This trial is sponsored by National Institute on Drug Abuse (NIDA), which has 335 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.